Hepatic encephalopathy: from pathophysiology to therapeutic management

Area of Science:

• Neuroscience
• Hepatology
• Internal Medicine

Background:

• Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome associated with acute or chronic liver disease.
• Clinical symptoms of HE range widely, from subtle neurological changes to deep coma.
• Ammonia is recognized as a primary neurotoxin in HE pathogenesis.

Purpose of the Study:

• To review the pathogenesis and clinical manifestations of hepatic encephalopathy.
• To highlight the role of ammonia and other contributing factors in HE.
• To discuss current management strategies and their limitations.

Main Methods:

• Literature review of hepatic encephalopathy.
• Analysis of the role of ammonia and other neurobiological mechanisms.
• Evaluation of current therapeutic approaches.

Main Results:

• Ammonia is the principal neurotoxin, but alterations in the blood-brain barrier, neurotransmission, and GABAergic pathways are also implicated.
• Precipitating factors significantly influence patient outcomes and require prompt identification and management.
• Current treatments aim to decrease intestinal ammonia production, using agents like antibiotics and disaccharides, though their effectiveness requires further validation.

Conclusions:

• Hepatic encephalopathy is a multifactorial condition requiring comprehensive management.
• Further research is needed to establish the definitive efficacy of current treatments for reducing ammonia load.
• Addressing precipitating factors is essential for effective HE management.